Publications

Detailed Information

Potential redox-sensitive Akt activation by dopamine activates Bad and promotes cell death in melanocytes

DC Field Value Language
dc.contributor.authorChoi, Hye-Ryung-
dc.contributor.authorShin, Jung-Won-
dc.contributor.authorLee, Hyun-Kyoung-
dc.contributor.authorKim, Jin-Young-
dc.contributor.authorYoun, Sang-Woong-
dc.contributor.authorPark, Kyoung Chan-
dc.contributor.authorHuh, Chang-Hun-
dc.date.accessioned2012-07-04T01:31:10Z-
dc.date.available2012-07-04T01:31:10Z-
dc.date.issued2010-06-
dc.identifier.citationOXIDATIVE MEDICINE AND CELLULAR LONGEVITY; Vol.3(3); 219-224ko_KR
dc.identifier.issn1942-0900-
dc.identifier.urihttps://hdl.handle.net/10371/78364-
dc.description.abstractDopamine (DA) is a well known oxidative neurotoxin. In addition, Akt has been reported to deliver a survival signal that inhibits apoptosis. However, it has also been reported that chronic Akt activation leads to apoptosis in response to oxidative stress. The objective of the present study was to investigate the possible role of the Akt pathway in vitiligo and its possible relationship with DA-induced cell death using Mel-Ab cells. Cultured Mel-Ab cells were treated with DA with and without N-Acetyl-L-cysteine (NAC), which is known to have antioxidative properties. Cell viability was then assessed by a crystal violet assay and Annexin staining was performed. The changes in the expression of Akt were analyzed by western blot analysis. The cell viability was reduced by approximately 60% in response to treatment with 500 mu M DA, and NAC effectively prevented this cytotoxic effect. Likewise, treatment with DA produced numerous Annexin positive cells, while treatment with NAC prevented this apoptotic cell death. Akt was slowly phosphorylated after treatment with DA, while NAC clearly inhibited the DA-induced Akt activation. Western blot analysis also showed that treatment with DA induced the activation of Bad. Finally, LY294002 exerted a protective effect against DA-induced apoptotic cell death. DA may induce redox-sensitive Akt activation and increase the level of Bad, which can promote cell death by heterodimerization with survival proteins. Moreover, NAC effectively protects against DA-induced melanocyte death via inhibition of DA-induced Akt activation.ko_KR
dc.language.isoenko_KR
dc.publisherLANDES BIOSCIENCEko_KR
dc.subjectAktko_KR
dc.subjectmelanocyteko_KR
dc.subjectdopamineko_KR
dc.subjectN-Acetyl-L-cysteineko_KR
dc.subjectbadko_KR
dc.titlePotential redox-sensitive Akt activation by dopamine activates Bad and promotes cell death in melanocytesko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor최혜령-
dc.contributor.AlternativeAuthor신정원-
dc.contributor.AlternativeAuthor이현경-
dc.contributor.AlternativeAuthor김진영-
dc.contributor.AlternativeAuthor허창훈-
dc.contributor.AlternativeAuthor윤상웅-
dc.contributor.AlternativeAuthor박경찬-
dc.identifier.doi10.4161/oxim.3.3.8-
dc.citation.journaltitleOXIDATIVE MEDICINE AND CELLULAR LONGEVITY-
dc.description.citedreferenceKIM W, 2010, J RADIAT RE IN PRESS-
dc.description.citedreferenceArciuch VGA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007523-
dc.description.citedreferenceFisher-Wellman K, 2009, OXID MED CELL LONGEV, V2, P43-
dc.description.citedreferenceLahaie-Collins V, 2008, OXID MED CELL LONGEV, V1, P54-
dc.description.citedreferenceDUFOUR C, 2008, AM J PHYSIOL-ENDOC M, V294, P794-
dc.description.citedreferencePark ES, 2007, J DERMATOL SCI, V47, P141, DOI 10.1016/j.jdermsci.2007.03.009-
dc.description.citedreferencevan Gorp AGM, 2006, CANCER RES, V66, P10760, DOI 10.1158/0008-5472.CAN-06-1111-
dc.description.citedreferenceLu B, 2006, J IMMUNOL, V176, P6785-
dc.description.citedreferenceCucchi ML, 2003, PIGM CELL RES, V16, P111-
dc.description.citedreferencePedrosa R, 2002, BRIT J PHARMACOL, V137, P1305, DOI 10.1038/sj.bjp.0704982-
dc.description.citedreferenceCho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200-
dc.description.citedreferenceBlum D, 2001, PROG NEUROBIOL, V65, P135-
dc.description.citedreferenceCho H, 2001, SCIENCE, V292, P1728-
dc.description.citedreferenceOka M, 2000, J INVEST DERMATOL, V115, P699-
dc.description.citedreferenceCucchi ML, 2000, PIGM CELL RES, V13, P28-
dc.description.citedreferenceMasure S, 1999, EUR J BIOCHEM, V265, P353-
dc.description.citedreferenceLaVoie MJ, 1999, J NEUROSCI, V19, P1484-
dc.description.citedreferenceCoffer PJ, 1998, BIOCHEM J, V335, P1-
dc.description.citedreferencedelPeso L, 1997, SCIENCE, V278, P687-
dc.description.citedreferenceAhmed NN, 1997, P NATL ACAD SCI USA, V94, P3627-
dc.description.citedreferenceKauffmanZeh A, 1997, NATURE, V385, P544-
dc.description.citedreferenceWhite E, 1996, GENE DEV, V10, P1-
dc.description.citedreferenceVERMES I, 1995, J IMMUNOL METHODS, V184, P39-
dc.description.citedreferenceYANG E, 1995, CELL, V80, P285-
dc.description.citedreferenceDOOLEY TP, 1994, SKIN PHARMACOL, V7, P188-
dc.description.citedreferenceMORRONE A, 1992, PIGM CELL RES, V5, P65-
dc.description.tc2-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share